This clinical trial will evaluate the presence of recurrent or persistent Cushing's in patients who have undergone primary treatment for the condition.
Click here to access the following third-party resource.
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Study Type: Observational
Age/Gender Requirements: 18 years+ (male/female)
Sponsor: Corcept Therapeutics
Purpose: To confirm “the presence of recurrent or persistent endogenous Cushing's syndrome in patients who have had primary surgical and/or radiation therapy for Cushing's disease and continue to manifest symptoms and signs of hypercortisolemia.”